Intellectual Property

Intellectual Property

Randy Lipsitz, Richard Moss, Aaron Frankel | Kramer Levin Naftalis & Frankel LLP

While there have been various changes to U.S. patent law in the years since the last significant revamping of the U.S. patent system in 1952, not any have been as sweeping in scope as the changes that recently became law through the Leahy-Smith America Invents Act (H.R. 1249). With campaign-style...

Healthcare | Life Sciences

Lori M. Waldron | Sills Cummis & Gross P.C.

A biotech or pharmaceutical company will often need to in-license certain inventions in order to develop and commercialize its products. The company will most likely be required to pay to its licensor a royalty based on sales of its products (licensed products) that exploit the licensed...

Intellectual Property

Carl C. Charneski | Brinks Hofer Gilson & Lione

Editor: Congratulations on joining Brinks Hofer Gilson & Lione (Brinks) in its U.S. International Trade Commission (ITC) practice. Please tell us about your background and experience. Charneski: Before joining Brinks, I was an ITC judge for four and a half years, though I often refer to...